Komori
Governance4539NIPPON CHEMIPHAR CO.,LTD.Pharmaceuticals

Independent Officer Notification Form

Effective 17 June 2026, Narita Manabu (成田 学) is scheduled to be designated as an independent officer in his capacity as an outside director and appointed as a member of the Compensation Advisory Committee.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Number of independent officers4Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Committee1
Compensation Advisory Committee: proportion of outside members: 非開示
Changes this time

The contents of the independent officer notification concerning Narita Manabu (成田 学) have been corrected and changed, and he is scheduled to be appointed as a member of the Compensation Advisory Committee effective 17 June 2026. Omukai Naoko (大向 尚子) meets the independence requirements but has not been reported as an independent officer in accordance with the policy of her law firm.

Governance structure
ItemDetails
Number of independent officers4 (2 outside directors and 2 outside corporate auditors)
CommitteeCompensation Advisory Committee: proportion of outside members: Not disclosed
Changes this timeThe contents of the independent officer notification concerning Narita Manabu (成田 学) have been corrected and changed, and he is scheduled to be appointed as a member of the Compensation Advisory Committee effective 17 June 2026. Omukai Naoko (大向 尚子) meets the independence requirements but has not been reported as an independent officer in accordance with the policy of her law firm.
Items this document does not state (5)
Corporate Governance StructureNumber of directorsPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because Narita Manabu (成田 学) is scheduled to be appointed as a member of the Compensation Advisory Committee on 17 June 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | NIPPON CHEMIPHAR CO.,LTD. (4539) timely disclosure | Komori